Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP001001

Drug Information
NamePefloxacin
SynonymsSMR000273037; Oprea1_546341; BRD-K55034111-066-02-3; 3-Quinolinecarboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-; 1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid; Pefloxacinum [INN-Latin]; Pefloxacine; Pefloxacin [INN-French]; Pefloxacin; Pefloxacin (USAN/INN); C17H20FN3O3; AC1Q5RD0; STOCK1S-14007; EINECS 274-611-8; Spectrum3_001971; CHEMBL267648; AKOS000280245; 1-ethyl-6-fluoro-7-(4-methyl-1-piperazinyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid; 1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-methyl-1-piperazinyl)-3-quinolinecarboxylic acid; Pefloxacin methanesulfonate; PERFLOXACIN; BRN 0567618; PFLX; MolPort-000-883-203; 70458-95-6 (MESYLATE); D02306; AM-725; MLS000713556; CHEBI:50199; LS-141589; Pefloxacinum; Peflacine; 2589 R.B; 1-Ethyl-6-fluoro-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-Ethyl-6-fluoro-1,4-dihydro-7-(4-methyl-1- piperazinyl)-4-oxo-3-quinolinecarboxylic acid; SPBio_000127; DB00487; Oprea1_063677; HMS1613E05; STK169677; MolPort-002-885-848; Abactal; KBio3_002945; Spectrum2_000034; Pefloxacino; BAS 00463355; 1589 RB; Labocton; 3-Quinolinecarboxylic acid, 1,4-dihydro-1-ethyl-6-fluoro-7-(4-methyl-1-piperazinyl)-4-oxo-; Pefloxacino [INN-Spanish]; 3-Quinolinecarboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo; CCRIS 8210; HMS2090H09; EU 5306; BSPBio_003571; 70458-92-3; EU-5306; 1584RB; Silver Pefloxacin; Pefloxacin [USAN:BAN:INN]; AC1L1AEA; UNII-2H52Z9F2Q5; CID51081
IndicationGonococcal urethritis in males
[ICD9: 098   ICD10: A54]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C17H20FN3O3/c1-3-20-10-12(17(23)24)16(22)11-8-13(18)15(9-14(11
)20)21-6-4-19(2)5-7-21/h8-10H,3-7H2,1-2H3,(H,23,24)
InChIKeyFHFYDNQZQSQIAI-UHFFFAOYSA-N
Canonical SMILESCCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O    
Therapeutic ClassAntiinfective Agents
CAS NumberCAS 70458-92-3
FormulaC17H20FN3O3
PubChem Compound IDCID 51081.
PubChem Substance IDSID 189349.
ChEBI50199;
SuperDrug ATC IDJ01MA03
SuperDrug CAS ID070458923;
TargetDNA gyraseInhibitor[2]
Ref 1Drug information of Pefloxacin, 2008 To Reference
Ref 2Clinical pharmacokinetics of the newer antibacterial 4-quinolones. Clin Pharmacokinet. 1988 Feb;14(2):96-121. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543